Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

FONAR Corporation (FONR)

20.5   -0.22 (-1.06%) 01-24 16:00
Open: 20.7 Pre. Close: 20.72
High: 20.73 Low: 20.365
Volume: 12,671 Market Cap: 135M
Fonar Corp is engaged in the research, development, production and marketing of medical scanning equipment. The Company operates in two segments manufacturing and servicing of medical equipment and management of diagnostic imaging centers.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.753 - 20.922 20.922 - 21.035
Low: 20.007 - 20.195 20.195 - 20.321
Close: 20.255 - 20.545 20.545 - 20.74

Technical analysis

as of: 2020-01-24 4:31:58 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 25.00     One year: 29.19
Support: Support1: 19.93    Support2: 19.02
Resistance: Resistance1: 21.40    Resistance2: 25.00
Pivot: 20.29
Moving Average: MA(5): 20.74     MA(20): 20.14
MA(100): 20.61     MA(250): 21.25
MACD: MACD(12,26): 0.24     Signal(9): 0.17
Stochastic oscillator: %K(14,3): 70.17     %D(3): 73.86
RSI: RSI(14): 53.87
52-week: High: 25.25  Low: 18.85  Change(%): -5.0
Average Vol(K): 3-Month: 2212  10-Days: 3901

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
FONR has closed below upper band by 42.0%. Bollinger Bands are 45.2% wider than normal. The large width of the bands suggest high volatility as compared to FONR's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 10 Nov 2017 17:00:33 +0000
Mid-Day Market Update: Omeros Climbs After Strong Q3 Results; LightPath Technologies Shares Plunge

Thu, 09 Nov 2017 08:00:00 +0000
Haemonetics Shows Market Leadership With Jump To 91 RS Rating

Wed, 08 Nov 2017 08:00:00 +0000
Stocks To Watch: Natus Medical Sees Relative Strength Rating Rise To 84

Wed, 08 Nov 2017 08:00:00 +0000
Haemonetics Earns Relative Strength Rating Upgrade; Hits Key Benchmark

Mon, 06 Nov 2017 08:00:00 +0000
Varian Medical Systems Earns Relative Strength Rating Upgrade; Hits Key Benchmark

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 6.45
Shares Float (M) 5.77
% Held by Insiders 3.15
% Held by Institutions 50.68
Shares Short (K) 11
Shares Short P. Month (K)

Stock Financials

EPS 2.220
Book Value (p.s.) 18.440
PEG Ratio
Profit Margin 17.34
Operating Margin 25.03
Return on Assets (ttm) 9.6
Return on Equity (ttm) 17.9
Qtrly Rev. Growth 5.0
Gross Profit (p.s.) 6.699
Sales Per Share
EBITDA (p.s.) 4.029
Qtrly Earnings Growth -0.60
Operating Cash Flow (M) 19.92
Levered Free Cash Flow (M) 5.43

Stock Valuations

P/E 9.23
P/E Growth Ratio -0.01
P/BV 1.11
P/S 1.54
P/CF 6.64

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1999-03-17
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.